Cargando…
RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation
Oestrogen receptor ɑ (ERɑ) is overexpressed in two‐thirds of all breast cancers and involves in development and breast cancer progression. Although ERɑ‐positive breast cancer could be effective treated by endocrine therapy, the endocrine resistance is still an urgent clinical problem. Thus, further...
Autores principales: | Liu, Zhenhua, Zhang, Jinghang, Xu, Juntao, Yang, Huijie, Li, Xin, Hou, Yingxiang, Zhao, Yan, Xue, Min, Wang, Beibei, Yu, Na, Yu, Sifan, Niu, Gang, Wu, Gaosong, Li, Xiumin, Wang, Hui, Zhu, Jian, Zhuang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111850/ https://www.ncbi.nlm.nih.gov/pubmed/29974997 http://dx.doi.org/10.1111/jcmm.13694 |
Ejemplares similares
-
STAT1 facilitates oestrogen receptor α transcription and stimulates breast cancer cell proliferation
por: Hou, Yingxiang, et al.
Publicado: (2018) -
RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1
por: Yu, Na, et al.
Publicado: (2018) -
SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells
por: Yang, Huijie, et al.
Publicado: (2018) -
SHARPIN Facilitates p53 Degradation in Breast Cancer Cells()()
por: Yang, Huijie, et al.
Publicado: (2017) -
Calling RNF168 to action
por: Nowsheen, Somaira, et al.
Publicado: (2018)